DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Thyrosafe is a drug marketed by Recip and is included in one NDA.
The generic ingredient in THYROSAFE is potassium iodide. There are two hundred and forty drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the potassium iodide profile page.
A generic version of THYROSAFE was approved as potassium iodide by MISSION PHARMACAL CO on March 24th, 2016.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Recip||THYROSAFE||potassium iodide||TABLET;ORAL||076350-001||Sep 10, 2002||OTC||No||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|